Evidence map›Paper›PMID 33627171›Full record

ArticleParasites & vectors2021

The Eagle effect in the Wolbachia-worm symbiosis.

Christina A Bulman, Laura Chappell, Emma Gunderson, Ian Vogel, Brenda Beerntsen, Barton E Slatko, William Sullivan, Judy A Sakanari

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Host plant-mediated effects onFrontiers in plant science · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Christina A BulmanDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-2359-8354
Laura ChappellDepartment of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, CA, USA.
Emma GundersonDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
Ian VogelDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
Brenda BeerntsenVeterinary Pathobiology, University of Missouri-Columbia, Columbia, MO, USA.
Barton E SlatkoMolecular Parasitology Division, New England Biolabs Inc, Ipswich, MA, USA.
William SullivanDepartment of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, CA, USA.
Judy A SakanariDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA. Judy.Sakanari@ucsf.edu.
University of California, San Francisco · USUniversity of California, Santa Cruz · USNew England Biolabs (United States) · USUniversity of Missouri · US

Funding

Bill and Melinda Gates Foundation OPP1017584
6 · The paper itself

Abstract

backgroundOnchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) are two human neglected tropical diseases that cause major disabilities. Mass administration of drugs targeting the microfilarial stage has reduced transmission and eliminated these diseases in several countries but a macrofilaricidal drug that kills or sterilizes the adult worms is critically needed to eradicate the diseases. The causative agents of onchocerciasis and lymphatic filariasis are filarial worms that harbor the endosymbiotic bacterium Wolbachia. Because filarial worms depend on Wolbachia for reproduction and survival, drugs targeting Wolbachia hold great promise as a means to eliminate these diseases.

methodsTo better understand the relationship between Wolbachia and its worm host, adult Brugia pahangi were exposed to varying concentrations of doxycycline, minocycline, tetracycline and rifampicin in vitro and assessed for Wolbachia numbers and worm motility. Worm motility was monitored using the Worminator system, and Wolbachia titers were assessed by qPCR of the single copy gene wsp from Wolbachia and gst from Brugia to calculate IC

resultsWorms treated with higher concentrations of antibiotics had higher Wolbachia titers, i.e. as antibiotic concentrations increased there was a corresponding increase in Wolbachia titers. As the concentration of antibiotic increased, worms stopped moving and never recovered despite maintaining Wolbachia titers comparable to controls. Thus, worms were rendered moribund by the higher concentrations of antibiotics but Wolbachia persisted suggesting that these antibiotics may act directly on the worms at high concentration. Surprisingly, in contrast to these results, antibiotics given at low concentrations reduced Wolbachia titers.

conclusionWolbachia in B. pahangi display a counterintuitive dose response known as the "Eagle effect." This effect in Wolbachia suggests a common underlying mechanism that allows diverse bacterial and fungal species to persist despite exposure to high concentrations of antimicrobial compounds. To our knowledge this is the first report of this phenomenon occurring in an intracellular endosymbiont, Wolbachia, in its filarial host.

Indexed as

SymbiosisAnimalsAnti-Bacterial AgentsBrugia malayiDoxycyclineFemaleMaleMicrofilariaeOnchocercaWolbachiaAnti-Bacterial AgentsDoxycyclineEagle effectEndosymbiosisFilariaWolbachia

Identifiers

PMID33627171
PMCPMC7905570
OpenAlexW3129339162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.